During the past decade, Clinique Sainte Anne conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 12 clinical trials were completed, i.e. on average, 34.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Sainte Anne" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 6 trials, followed by "Pfizer" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Merck Sharp & Dohme LLC" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Sainte Anne" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "Solasia Pharma K.K." with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Baxter Healthcare Corporation" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Sainte Anne" are "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Metastatic Colorectal Cancer" (3 trials), "Prostatic Neoplasms" (3 trials) and "Chemotherapy-induced Peripheral Neuropathy" (2 trials). Many other conditions were trialed in "Clinique Sainte Anne" in a lesser frequency.

Most popular intervention types in "Clinique Sainte Anne" are "Drug" (36 trials), "Biological" (7 trials), "Other" (5 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Pembrolizumab" (5 trials), "Bevacizumab" (4 trials), "Prednisone" (4 trials) and "Avelumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Sainte Anne" are 36 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Sainte Anne". undefined are not yet recruiting, 10 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Clinique Sainte Anne, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Sainte Anne, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".